Xarelto Lawsuit Filed After Vermont Man Dies

October 15, 2015 – – BloodThinnerHelp.com reports on another Xarelto lawsuit filed in Vermont after a father died from uncontrollable internal bleeding. The lawsuit, filed by the daughter of the deceased, alleges that prescription Xarelto caused the victim’s internal bleeding and eventual death. The man was said to be taking Xarelto in order to prevent blood clots and strokes due to his atrial fibrillation condition.

The victim first began using Xarelto after being prescribed the drug by his doctor in July of 2012. After six long days in the hospital, the man passed away on August 1st of 2012. At the time of his death, his system still contained active Xarelto, which likely prevented his blood from clotting while he hemorrhaged.

The daughter of the deceased also lives in Vermont, and has now filed a lawsuit on behalf of her father. She seeks compensation for medical expenses, attorneys fees, funeral and burial fees, and pain and suffering, among other things. Her complaint alleges that if her father had been made aware of the risks associated with the drug, they would have chosen a safer alternative. Additionally, she alleges that Janssen Pharmaceuticals (a division of Johnson & Johnson) and Bayer AG proved to be negligent and reckless by marketing a drug like Xarelto.

By many of the recent lawsuits, Xarelto is alleged to be a more dangerous drug than other blood thinners because of the fact that it has no antidote. If a patient taking an alternative type of blood thinner becomes injured and bleeds, doctors are able to administer vitamin K which negates the effects of the blood thinner and forces the blood to clot again. If a patient taking Xarelto suffers injuries and begins to bleed vitamin K cannot reverse its effects, and the blood is unable to clot. In these instances, doctors have to resort to life-saving measures such as blood transfusions.

As these instances continue to occur among patients using Xarelto, the number of lawsuits filed against the drug company grows. Just a few months ago, the lawsuits were consolidated into a Xarelto multidistrict litigation, or MDL. Court documents highlighted around 1,200 lawsuits that had been consolidated into MDL 2592 toward the end of August. At the end of September, Case Management Order #2 was issued by the Court. Additionally, the FDA has attached two ‘Black Box’ warnings to the product. These are the most strict warnings possible. The next step would likely be a recall of the product mandated by the FDA.

Xarelto attorney Marc Goldich noted “We expect Xarelto lawsuits to continue to appear. If the drug’s manufacturers were in fact aware of the dangers it presented and yet neglected to properly warn the public, it is important that they be held responsible for these actions.”

Marc Goldich, Esq. encourages anyone who has suffered health issues after using Xarelto to reach out and learn more abouttheir rights. “They may be entitled to compensation for their suffering,” he states. To explore your rights or ask questions, contact Mark Goldich, Esq. by calling (866) 425-8902 at your convenience.

###

Contact BloodThinnerHelp.com:

Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.

ReleaseID: 60004718